[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @GrupoTTD Grupo Español de Tratamiento de Tumores Digestivos Grupo Español de Tratamiento de Tumores Digestivos posts on X about checkpoint the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1384516755041685505/interactions)  - X Months XXX -XX% - X Year XXXXX +32% ### Mentions: X [#](/creator/twitter::1384516755041685505/posts_active)  ### Followers: XXXXX [#](/creator/twitter::1384516755041685505/followers)  - X Months XXXXX +12% - X Year XXXXX +16% ### CreatorRank: undefined [#](/creator/twitter::1384516755041685505/influencer_rank)  ### Social Influence [#](/creator/twitter::1384516755041685505/influence) --- **Social topic influence** [checkpoint](/topic/checkpoint) ### Top Social Posts [#](/creator/twitter::1384516755041685505/posts) --- Top posts by engagements in the last XX hours "📍Checkpoint inhibitor benefit in perioperative gastro-esophageal cancer Meta-analysis of phase3trials(MATTERHORN&KEYNOTE-585) ✅FLOT+IOCis/5FU+IO for EFS (HR 0.79; p=0.021) 👉IO+FLOT emerges as standard-of-care candidate in resectable GE adenocarcinoma" [X Link](https://x.com/GrupoTTD/status/1980938141226721386) [@GrupoTTD](/creator/x/GrupoTTD) 2025-10-22T10:03Z 1537 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Grupo Español de Tratamiento de Tumores Digestivos posts on X about checkpoint the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence checkpoint
Top posts by engagements in the last XX hours
"📍Checkpoint inhibitor benefit in perioperative gastro-esophageal cancer Meta-analysis of phase3trials(MATTERHORN&KEYNOTE-585) ✅FLOT+IOCis/5FU+IO for EFS (HR 0.79; p=0.021) 👉IO+FLOT emerges as standard-of-care candidate in resectable GE adenocarcinoma"
X Link @GrupoTTD 2025-10-22T10:03Z 1537 followers, XXX engagements
/creator/x::GrupoTTD